The significant risk factors include abnormal serum carcinoembryonic antigen levels, solid part tumor diameter ≥ 1.3 cm, and consolidation–tumor ratio ≥ 0.50 on chest computed tomography. This evidence concerns the gene CEACAM5 and neoplasm.